Core Patient-Reported Outcomes in Cancer Clinical Trials: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 17, 2024
October 17, 2024
a5111d3d-2d0d-4753-9773-d2f2a25c85fb
Related Documents
Real-Time Oncology Review (RTOR) : Guidance for Industry
Guidance DocumentNovember 7, 2023Office of the Commissioner
Inclusion of Older Adults in Cancer Clinical Trials: Guidance for Industry
Guidance DocumentMarch 2, 2022Office of the Commissioner
Multiple Endpoints in Clinical Trials: Guidance for Industry
Guidance DocumentOctober 21, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox